-
1
-
-
82555196095
-
Systemic lupus erythematosus
-
Tsokos, G. C. 2011. Systemic lupus erythematosus. N. Engl. J. Med. 365:2110-2121.
-
(2011)
N. Engl. J. Med.
, vol.365
, pp. 2110-2121
-
-
Tsokos, G.C.1
-
2
-
-
67849126802
-
Three checkpoints in lupus development: Central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation
-
Kanta, H., and C. Mohan. 2009. Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation. Genes Immun. 10:390-396.
-
(2009)
Genes Immun.
, vol.10
, pp. 390-396
-
-
Kanta, H.1
Mohan, C.2
-
3
-
-
84876282977
-
Recent insights into the genetic basis of systemic lupus erythematosus
-
Rullo, O. J., and B. P. Tsao. 2013. Recent insights into the genetic basis of systemic lupus erythematosus. Ann. Rheum. Dis. 72(Suppl. 2):ii56-ii61.
-
(2013)
Ann. Rheum. Dis.
, vol.72
, pp. ii56-ii61
-
-
Rullo, O.J.1
Tsao, B.P.2
-
4
-
-
79958255101
-
Autoantibodies in systemic lupus erythematosus: Comparison of historical and current assessment of seropositivity
-
Ippolito, A., D. J. Wallace, D. Gladman, P. R. Fortin, M. Urowitz, V. Werth, M. Costner, C. Gordon, G. S. Alarcón, R. Ramsey-Goldman, et al. 2011. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus 20:250-255.
-
(2011)
Lupus
, vol.20
, pp. 250-255
-
-
Ippolito, A.1
Wallace, D.J.2
Gladman, D.3
Fortin, P.R.4
Urowitz, M.5
Werth, V.6
Costner, M.7
Gordon, C.8
Alarcón, G.S.9
Ramsey-Goldman, R.10
-
5
-
-
60749095446
-
Antigen receptor signaling in the rheumatic diseases
-
Zikherman, J., and A. Weiss. 2009. Antigen receptor signaling in the rheumatic diseases. Arthritis Res. Ther. 11:202.
-
(2009)
Arthritis Res. Ther.
, vol.11
, pp. 202
-
-
Zikherman, J.1
Weiss, A.2
-
6
-
-
61849136595
-
CD45, CD148, and Lyp/Pep: Critical phosphatases regulating Src family kinase signaling networks in immune cells
-
Hermiston, M. L., J. Zikherman, and J. W. Zhu. 2009. CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells. Immunol. Rev. 228:288-311.
-
(2009)
Immunol. Rev.
, vol.228
, pp. 288-311
-
-
Hermiston, M.L.1
Zikherman, J.2
Zhu, J.W.3
-
7
-
-
0034704180
-
An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity
-
Majeti, R., Z. Xu, T. G. Parslow, J. L. Olson, D. I. Daikh, N. Killeen, and A. Weiss. 2000. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103:1059-1070.
-
(2000)
Cell
, vol.103
, pp. 1059-1070
-
-
Majeti, R.1
Xu, Z.2
Parslow, T.G.3
Olson, J.L.4
Daikh, D.I.5
Killeen, N.6
Weiss, A.7
-
8
-
-
28844498739
-
The juxtamembrane wedge negatively regulates CD45 function in B cells
-
Hermiston, M. L., A. L. Tan, V. A. Gupta, R. Majeti, and A. Weiss. 2005. The juxtamembrane wedge negatively regulates CD45 function in B cells. Immunity 23:635-647.
-
(2005)
Immunity
, vol.23
, pp. 635-647
-
-
Hermiston, M.L.1
Tan, A.L.2
Gupta, V.A.3
Majeti, R.4
Weiss, A.5
-
9
-
-
58149296185
-
B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency
-
Gupta, V. A., M. L. Hermiston, G. Cassafer, D. I. Daikh, and A. Weiss. 2008. B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency. J. Exp. Med. 205:2755-2761.
-
(2008)
J. Exp. Med.
, vol.205
, pp. 2755-2761
-
-
Gupta, V.A.1
Hermiston, M.L.2
Cassafer, G.3
Daikh, D.I.4
Weiss, A.5
-
10
-
-
64249119896
-
PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background
-
Zikherman, J., M. Hermiston, D. Steiner, K. Hasegawa, A. Chan, and A. Weiss. 2009. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J. Immunol. 182:4093-4106.
-
(2009)
J. Immunol.
, vol.182
, pp. 4093-4106
-
-
Zikherman, J.1
Hermiston, M.2
Steiner, D.3
Hasegawa, K.4
Chan, A.5
Weiss, A.6
-
11
-
-
58849083208
-
Differential impact of the CD45 juxtamembrane wedge on central and peripheral T cell receptor responses
-
Hermiston, M. L., J. Zikherman, A. L. Tan, V. C. Lam, N. M. Cresalia, N. Oksenberg, N. Goren, D. Brassat, J. R. Oksenberg, and A. Weiss. 2009. Differential impact of the CD45 juxtamembrane wedge on central and peripheral T cell receptor responses. Proc. Natl. Acad. Sci. USA 106:546-551.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 546-551
-
-
Hermiston, M.L.1
Zikherman, J.2
Tan, A.L.3
Lam, V.C.4
Cresalia, N.M.5
Oksenberg, N.6
Goren, N.7
Brassat, D.8
Oksenberg, J.R.9
Weiss, A.10
-
12
-
-
84874859983
-
The structural wedge domain of the receptor-like tyrosine phosphatase CD45 enforces B cell tolerance by regulating substrate specificity
-
Zikherman, J., R. Parameswaran, M. Hermiston, and A. Weiss. 2013. The structural wedge domain of the receptor-like tyrosine phosphatase CD45 enforces B cell tolerance by regulating substrate specificity. J. Immunol. 190:2527-2535.
-
(2013)
J. Immunol.
, vol.190
, pp. 2527-2535
-
-
Zikherman, J.1
Parameswaran, R.2
Hermiston, M.3
Weiss, A.4
-
13
-
-
0034619794
-
A Toll-like receptor recognizes bacterial DNA
-
Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
-
(2000)
Nature
, vol.408
, pp. 740-745
-
-
Hemmi, H.1
Takeuchi, O.2
Kawai, T.3
Kaisho, T.4
Sato, S.5
Sanjo, H.6
Matsumoto, M.7
Hoshino, K.8
Wagner, H.9
Takeda, K.10
Akira, S.11
-
14
-
-
0142009533
-
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
-
Arbuckle, M. R., M. T. McClain, M. V. Rubertone, R. H. Scofield, G. J. Dennis, J. A. James, and J. B. Harley. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349:1526-1533.
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 1526-1533
-
-
Arbuckle, M.R.1
McClain, M.T.2
Rubertone, M.V.3
Scofield, R.H.4
Dennis, G.J.5
James, J.A.6
Harley, J.B.7
-
15
-
-
0028877463
-
Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
-
Lander, E., and L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genet. 11:241-247.
-
(1995)
Nature Genet.
, vol.11
, pp. 241-247
-
-
Lander, E.1
Kruglyak, L.2
-
16
-
-
0034816964
-
Delineating the genetic basis of systemic lupus erythematosus
-
Wakeland, E. K., K. Liu, R. R. Graham, and T. W. Behrens. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397-408.
-
(2001)
Immunity
, vol.15
, pp. 397-408
-
-
Wakeland, E.K.1
Liu, K.2
Graham, R.R.3
Behrens, T.W.4
-
18
-
-
34250650116
-
TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: Results from a genome-wide scan
-
Anderson, A. E., M. L. Worku, W. Khamri, K. B. Bamford, M. M. Walker, and M. R. Thursz. 2007. TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: results from a genome-wide scan. Eur. J. Immunol. 37:1548-1561.
-
(2007)
Eur. J. Immunol.
, vol.37
, pp. 1548-1561
-
-
Anderson, A.E.1
Worku, M.L.2
Khamri, W.3
Bamford, K.B.4
Walker, M.M.5
Thursz, M.R.6
-
19
-
-
68849085894
-
A cell biological view of Toll-like receptor function: Regulation through compartmentalization
-
Barton, G. M., and J. C. Kagan. 2009. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat. Rev. Immunol. 9:535-542.
-
(2009)
Nat. Rev. Immunol.
, vol.9
, pp. 535-542
-
-
Barton, G.M.1
Kagan, J.C.2
-
20
-
-
0037061453
-
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
-
Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607.
-
(2002)
Nature
, vol.416
, pp. 603-607
-
-
Leadbetter, E.A.1
Rifkin, I.R.2
Hohlbaum, A.M.3
Beaudette, B.C.4
Shlomchik, M.J.5
Marshak-Rothstein, A.6
-
21
-
-
79953162780
-
Toll-like receptor driven B cell activation in the induction of systemic autoimmunity
-
Green, N. M., and A. Marshak-Rothstein. 2011. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin. Immunol. 23:106-112.
-
(2011)
Semin. Immunol.
, vol.23
, pp. 106-112
-
-
Green, N.M.1
Marshak-Rothstein, A.2
-
22
-
-
33748472865
-
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus
-
Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25:417-428.
-
(2006)
Immunity
, vol.25
, pp. 417-428
-
-
Christensen, S.R.1
Shupe, J.2
Nickerson, K.3
Kashgarian, M.4
Flavell, R.A.5
Shlomchik, M.J.6
-
23
-
-
77949903821
-
TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus
-
Nickerson, K. M., S. R. Christensen, J. Shupe, M. Kashgarian, D. Kim, K. Elkon, and M. J. Shlomchik. 2010. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J. Immunol. 184:1840-1848.
-
(2010)
J. Immunol.
, vol.184
, pp. 1840-1848
-
-
Nickerson, K.M.1
Christensen, S.R.2
Shupe, J.3
Kashgarian, M.4
Kim, D.5
Elkon, K.6
Shlomchik, M.J.7
-
24
-
-
34547772125
-
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
-
Groom, J. R., C. A. Fletcher, S. N. Walters, S. T. Grey, S. V. Watt, M. J. Sweet, M. J. Smyth, C. R. Mackay, and F. Mackay. 2007. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J. Exp. Med. 204:1959-1971.
-
(2007)
J. Exp. Med.
, vol.204
, pp. 1959-1971
-
-
Groom, J.R.1
Fletcher, C.A.2
Walters, S.N.3
Grey, S.T.4
Watt, S.V.5
Sweet, M.J.6
Smyth, M.J.7
Mackay, C.R.8
Mackay, F.9
-
25
-
-
78649848107
-
TAM receptor signaling and autoimmune disease
-
Rothlin, C. V., and G. Lemke. 2010. TAM receptor signaling and autoimmune disease. Curr. Opin. Immunol. 22:740-746.
-
(2010)
Curr. Opin. Immunol.
, vol.22
, pp. 740-746
-
-
Rothlin, C.V.1
Lemke, G.2
-
26
-
-
77955343903
-
Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice
-
Scapini, P., Y. Hu, C. L. Chu, T. S. Migone, A. L. Defranco, M. A. Cassatella, and C. A. Lowell. 2010. Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J. Exp. Med. 207:1757-1773.
-
(2010)
J. Exp. Med.
, vol.207
, pp. 1757-1773
-
-
Scapini, P.1
Hu, Y.2
Chu, C.L.3
Migone, T.S.4
Defranco, A.L.5
Cassatella, M.A.6
Lowell, C.A.7
-
27
-
-
78149298238
-
Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis
-
Summers, S. A., O. M. Steinmetz, J. D. Ooi, P. Y. Gan, K. M. O'Sullivan, K. Visvanathan, S. Akira, A. R. Kitching, and S. R. Holdsworth. 2010. Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis. Am. J. Pathol. 177:2234-2244.
-
(2010)
Am. J. Pathol.
, vol.177
, pp. 2234-2244
-
-
Summers, S.A.1
Steinmetz, O.M.2
Ooi, J.D.3
Gan, P.Y.4
O'Sullivan, K.M.5
Visvanathan, K.6
Akira, S.7
Kitching, A.R.8
Holdsworth, S.R.9
-
28
-
-
84870250088
-
Toll-like receptor 9 and vascular endothelial growth factor levels in human kidneys from lupus nephritis patients
-
Frieri, M., M. A. Samih, M. Dzhindzhikhashvili, H. Liu, L. Balsam, and S. Rubinstein. 2012. Toll-like receptor 9 and vascular endothelial growth factor levels in human kidneys from lupus nephritis patients. J. Nephrol. 25:1041-1046.
-
(2012)
J. Nephrol.
, vol.25
, pp. 1041-1046
-
-
Frieri, M.1
Samih, M.A.2
Dzhindzhikhashvili, M.3
Liu, H.4
Balsam, L.5
Rubinstein, S.6
-
29
-
-
74049110516
-
Checkpoints in lymphocyte development and autoimmune disease
-
Von Boehmer, H., and F. Melchers. 2010. Checkpoints in lymphocyte development and autoimmune disease. Nat. Immunol. 11:14-20.
-
(2010)
Nat. Immunol.
, vol.11
, pp. 14-20
-
-
Von Boehmer, H.1
Melchers, F.2
-
30
-
-
84923869887
-
Lupus nephritis susceptibility Loci in women with systemic lupus erythematosus
-
Chung, S. A., E. E. Brown, A. H. Williams, P. S. Ramos, C. C. Berthier, T. Bhangale, M. E. Alarcon-Riquelme, T. W. Behrens, L. A. Criswell, D. C. Graham, et al; International Consortium for Systemic Lupus Erythematosus Genetics. 2014. Lupus nephritis susceptibility Loci in women with systemic lupus erythematosus. J. Am. Soc. Nephrol. 25:2859-2870.
-
(2014)
J. Am. Soc. Nephrol.
, vol.25
, pp. 2859-2870
-
-
International Consortium for Systemic Lupus Erythematosus Genetics1
Chung, S.A.2
Brown, E.E.3
Williams, A.H.4
Ramos, P.S.5
Berthier, C.C.6
Bhangale, T.7
Alarcon-Riquelme, M.E.8
Behrens, T.W.9
Criswell, L.A.10
Graham, D.C.11
-
31
-
-
31044440025
-
Toll-like receptor 9 signaling protects against murine lupus
-
Wu, X., and S. L. Peng. 2006. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum. 54:336-342.
-
(2006)
Arthritis Rheum.
, vol.54
, pp. 336-342
-
-
Wu, X.1
Peng, S.L.2
-
32
-
-
33748465308
-
Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE
-
Yu, P., U. Wellmann, S. Kunder, L. Quintanilla-Martinez, L. Jennen, N. Dear, K. Amann, S. Bauer, T. H. Winkler, and H. Wagner. 2006. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int. Immunol. 18:1211-1219.
-
(2006)
Int. Immunol.
, vol.18
, pp. 1211-1219
-
-
Yu, P.1
Wellmann, U.2
Kunder, S.3
Quintanilla-Martinez, L.4
Jennen, L.5
Dear, N.6
Amann, K.7
Bauer, S.8
Winkler, T.H.9
Wagner, H.10
-
33
-
-
33745864016
-
Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus
-
Lartigue, A., P. Courville, I. Auquit, A. François, C. Arnoult, F. Tron, D. Gilbert, and P. Musette. 2006. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J. Immunol. 177:1349-1354.
-
(2006)
J. Immunol.
, vol.177
, pp. 1349-1354
-
-
Lartigue, A.1
Courville, P.2
Auquit, I.3
François, A.4
Arnoult, C.5
Tron, F.6
Gilbert, D.7
Musette, P.8
-
34
-
-
80052851950
-
Mouse genomic variation and its effect on phenotypes and gene regulation
-
Keane, T. M., L. Goodstadt, P. Danecek, M. A. White, K. Wong, B. Yalcin, A. Heger, A. Agam, G. Slater, M. Goodson, et al. 2011. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477:289-294.
-
(2011)
Nature
, vol.477
, pp. 289-294
-
-
Keane, T.M.1
Goodstadt, L.2
Danecek, P.3
White, M.A.4
Wong, K.5
Yalcin, B.6
Heger, A.7
Agam, A.8
Slater, G.9
Goodson, M.10
-
35
-
-
84893344016
-
TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice
-
Desnues, B., A. B. Macedo, A. Roussel-Queval, J. Bonnardel, S. Henri, O. Demaria, and L. Alexopoulou. 2014. TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice. Proc. Natl. Acad. Sci. USA 111:1497-1502.
-
(2014)
Proc. Natl. Acad. Sci. USA
, vol.111
, pp. 1497-1502
-
-
Desnues, B.1
Macedo, A.B.2
Roussel-Queval, A.3
Bonnardel, J.4
Henri, S.5
Demaria, O.6
Alexopoulou, L.7
-
36
-
-
84873557459
-
TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation
-
Nickerson, K. M., S. R. Christensen, J. L. Cullen, W. Meng, E. T. Luning Prak, and M. J. Shlomchik. 2013. TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation. J. Immunol. 190:1447-1456.
-
(2013)
J. Immunol.
, vol.190
, pp. 1447-1456
-
-
Nickerson, K.M.1
Christensen, S.R.2
Cullen, J.L.3
Meng, W.4
Luning Prak, E.T.5
Shlomchik, M.J.6
-
37
-
-
55349142293
-
IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans
-
Isnardi, I., Y. S. Ng, I. Srdanovic, R. Motaghedi, S. Rudchenko, H. Von Bernuth, S. Y. Zhang, A. Puel, E. Jouanguy, C. Picard, et al. 2008. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29:746-757.
-
(2008)
Immunity
, vol.29
, pp. 746-757
-
-
Isnardi, I.1
Ng, Y.S.2
Srdanovic, I.3
Motaghedi, R.4
Rudchenko, S.5
Von Bernuth, H.6
Zhang, S.Y.7
Puel, A.8
Jouanguy, E.9
Picard, C.10
-
39
-
-
84863760911
-
Associations between TLR polymorphisms and systemic lupus erythematosus: A systematic review and meta-analysis
-
Lee, Y. H., H. S. Lee, S. J. Choi, J. D. Ji, and G. G. Song. 2012. Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clin. Exp. Rheumatol. 30:262-265.
-
(2012)
Clin. Exp. Rheumatol.
, vol.30
, pp. 262-265
-
-
Lee, Y.H.1
Lee, H.S.2
Choi, S.J.3
Ji, J.D.4
Song, G.G.5
-
40
-
-
84865389006
-
Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: A meta-analysis
-
Li, J., J. H. Tao, W. Gao, Y. Fan, M. M. Lu, R. Li, X. P. Li, and D. Q. Ye. 2012. Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis. Mod. Rheumatol. 22:550-556.
-
(2012)
Mod. Rheumatol.
, vol.22
, pp. 550-556
-
-
Li, J.1
Tao, J.H.2
Gao, W.3
Fan, Y.4
Lu, M.M.5
Li, R.6
Li, X.P.7
Ye, D.Q.8
-
41
-
-
84855444149
-
TLR9 polymorphisms and systemic lupus erythematosus risk in Asians: A meta-analysis study
-
Yang, Z., Y. Liang, B. Qin, C. Li, and R. Zhong. 2012. TLR9 polymorphisms and systemic lupus erythematosus risk in Asians: a meta-analysis study. Cytokine 57:282-289.
-
(2012)
Cytokine
, vol.57
, pp. 282-289
-
-
Yang, Z.1
Liang, Y.2
Qin, B.3
Li, C.4
Zhong, R.5
-
42
-
-
84875282770
-
Hydroxychloroquine in lupus: Emerging evidence supporting multiple beneficial effects
-
Tang, C., T. Godfrey, R. Stawell, and M. Nikpour. 2012. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects. Intern. Med. J. 42:968-978.
-
(2012)
Intern. Med. J.
, vol.42
, pp. 968-978
-
-
Tang, C.1
Godfrey, T.2
Stawell, R.3
Nikpour, M.4
-
43
-
-
77953723966
-
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
-
Guiducci, C., M. Gong, Z. Xu, M. Gill, D. Chaussabel, T. Meeker, J. H. Chan, T. Wright, M. Punaro, S. Bolland, et al. 2010. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 465:937-941.
-
(2010)
Nature
, vol.465
, pp. 937-941
-
-
Guiducci, C.1
Gong, M.2
Xu, Z.3
Gill, M.4
Chaussabel, D.5
Meeker, T.6
Chan, J.H.7
Wright, T.8
Punaro, M.9
Bolland, S.10
-
44
-
-
37549066665
-
Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms
-
Barrat, F. J., T. Meeker, J. H. Chan, C. Guiducci, and R. L. Coffman. 2007. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur. J. Immunol. 37:3582-3586.
-
(2007)
Eur. J. Immunol.
, vol.37
, pp. 3582-3586
-
-
Barrat, F.J.1
Meeker, T.2
Chan, J.H.3
Guiducci, C.4
Coffman, R.L.5
-
46
-
-
84872801225
-
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
-
Galluzzi, L., E. Vacchelli, A. Eggermont, W. H. Fridman, J. Galon, C. Sautès-Fridman, E. Tartour, L. Zitvogel, and G. Kroemer. 2012. Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. OncoImmunology 1:699-716.
-
(2012)
OncoImmunology
, vol.1
, pp. 699-716
-
-
Galluzzi, L.1
Vacchelli, E.2
Eggermont, A.3
Fridman, W.H.4
Galon, J.5
Sautès-Fridman, C.6
Tartour, E.7
Zitvogel, L.8
Kroemer, G.9
|